DBV Technologies S.A. (DBVT)

DBV Technologies S.A. (DBVT) is a healthcare company (biotechnology) based in France. The share price is $9.91, down 3.51% on the day, which values the company at $622.75M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$9.91−3.51% today
Market value
$622.75M
200-week average
$7.4533% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

DBV Technologies S.A. in more detail

DBVT trades at -25.5× next year's expected earnings, 166.7× sales. It sits 33% above its 200-week average of $7.45.

In its favour: More cash than debt. Worth checking: Share count keeps rising.

2 of the superinvestors tracked here hold DBVT, including Stanley Druckenmiller (0.1% of the portfolio), Julian and Felix Baker (0.1% of the portfolio).

Superinvestors holding DBVT

2 of the investors tracked here report a position in their latest 13F filing.

DBV Technologies S.A. (DBVT): questions and answers

What is DBV Technologies S.A.'s market cap?

DBV Technologies S.A. is valued at $622.75M at a share price of $9.91.

Is DBVT above its 200-week moving average?

Yes. DBVT is 33.1% above its 200-week average of $7.45. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DBVT pay a dividend?

DBV Technologies S.A. does not currently pay a regular dividend.

Which famous investors own DBVT?

In their latest quarterly filings, Stanley Druckenmiller (0.1% of the portfolio), Julian and Felix Baker (0.1% of the portfolio) hold DBVT. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “DBV Technologies S.A. (DBVT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DBVT

Underlying data: Yahoo Finance; company filings with the SEC.